Clinical trialNCT01153347CompletedPhase 3Interventional

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

SponsorAstraZenecaEnrollment2,409DepressionMajor Depressive Disorder

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Andrew J. Cutler, MD
Florida Clinical Research Center, LLC
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Hans A. Eriksson, MD,PhD, MBA
AstraZeneca
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

99 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

India

Research Site
Guntur, Andhra Pradesh, India
Research Site
Vijayawada, Andhra Pradesh, India
Research Site
Visakhapatnam, Andhra Pradesh, India
Research Site
Anand, Gujarat, India
Research Site
Jūnāgadh, Gujarat, India
Research Site
Rajkot, Gujarat, India
Research Site
Vadodara, Gujarat, India
Research Site
Bangalore, Karnataka, India
Research Site
Nashik, Mahara, India
Research Site
Aurangabad, Maharashtra, India
Research Site
Pune, Maharashtra, India
Research Site
Durham, NC, India
Research Site
Chennai, Tamil Nadu, India
Research Site
Madurai, Tamil Nadu, India
Research Site
Varanasi, Uttar Prad, India
Research Site
Lucknow, Uttar Pradesh, India
Research Site
Kanpur, India
Research Site
Karnataka, India
Research Site
Mysore, India

Puerto Rico

Research Site
San Juan, Puerto Rico

United States

Research Site
Birmingham, Alabama, United States
Research Site
Tucson, Arizona, United States
Research Site
Conway, Arkansas, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Arcadia, California, United States
Research Site
Beverly Hills, California, United States
Research Site
Garden Grove, California, United States
Research Site
Los Angeles, California, United States
Research Site
Newport Beach, California, United States
Research Site
Oakland, California, United States
Research Site
Oceanside, California, United States
Research Site
Pico Rivera, California, United States
Research Site
Santa Ana, California, United States
Research Site
Upland, California, United States
Research Site
Denver, Colorado, United States
Research Site
Cromwell, Connecticut, United States
Research Site
New London, Connecticut, United States
Research Site
Norwich, Connecticut, United States
Research Site
Washington D.C., District of Columbia, United States
Research Site
Bradenton, Florida, United States

59 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2010
Primary completion: 31 Jan 2012
Completion: 31 Jan 2012
Last update posted: 11 Apr 2014
Registered enrollment: 2,409
Registry id: NCT01153347

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.